Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Novozymes And Beta Renewables Form Cellulosic Ethanol Partnership

Ethanol: Novozymes joins Beta Renewables in commercial partnership

by Alex Scott
November 5, 2012 | A version of this story appeared in Volume 90, Issue 45

[+]Enlarge
Credit: Novozymes
Novozymes will produce enzymes for cellulosic ethanol at existing facilities such as this one in Kalundborg, Denmark.
Aerial view of Novozymes’ Danish enzymes plant.
Credit: Novozymes
Novozymes will produce enzymes for cellulosic ethanol at existing facilities such as this one in Kalundborg, Denmark.

Danish enzyme producer Novozymes and Italian cellulosic biofuels firm Beta Renewables are combining their technologies for manufacturing ethanol from cellulosic biomass to meet what they expect will be a multi-billion-dollar market opportunity.

Their agreement calls for Novozymes to acquire a 10% stake in Beta Renewables, a joint venture owned by the U.S. private equity firm TPG Capital and Italy’s Mossi & Ghisolfi, for $116 million in cash. The payment includes marketing fees and some intellectual property rights and is subject to Beta Renewables meeting certain milestones. Novozymes becomes a preferred supplier of enzymes to break down biomass in the Italian firm’s Proesa cellulosic ethanol process.

Novozymes, the world’s biggest enzyme company, forecasts that Beta Renewables will sign technology licensing agreements with third parties for 15 to 25 new cellulosic ethanol facilities during the next three to five years, netting the Danish firm total annual sales of up to $175 million.

The two companies will guarantee biofuel production costs upon start-up of customers’ ethanol facilities. “This type of complete offering will significantly de-risk cellulosic biofuel projects financially as well as technologically for our customers,” says Beta Renewables CEO Guido Ghisolfi.

In a briefing for analysts and journalists following the announcement of the venture, Novozymes was probed by JPMorgan Chase stock analyst Silke Kueck-Valdes about the scale of the opportunity for the enzyme firm. Peder Holk Nielsen, head of Novozymes’ enzyme business, responded that plants based on the Proesa technology will each likely produce 15 million to 40 million gal of ethanol per year but that enzyme consumption will depend on the type of biomass pretreatment selected.

The deal between the two firms comes just as Beta Renewables is commissioning the world’s first commercial-scale cellulosic ethanol plant, in Crescentino, Italy (see page 22). Other firms are also advancing cellulosic ethanol. Colorado-based start-up ZeaChem, for example, said it has completed construction of a 250,000-gal-per-year cellulosic ethanol facility in Boardman, Ore.

Not everyone wants to build plants, though. Late last month, BP ditched plans to build a $300 million cellulosic ethanol plant in Florida and says it now intends only to license its technology.

Advertisement

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.